Purdue Pharma Says It Will Cease Marketing OxyContin

Purdue Pharma, one of the largest manufacturers of Oxycontin in America, has vowed to stop marketing the opioid to doctors. Oxycontin is an opioid medication that has been on the market for over 20 years and is viewed by many addiction and law enforcement professionals to be the catalyst for America’s current opioid addiction crisis. It’s a common drug of abuse and is often responsible for overdoses. Purdue released a statement saying that it would no longer send sales representatives to market the opioid painkiller at doctor’s offices and that the Medical Affairs office will now handle all Oxycontin orders and queries. Many people involved in the addiction industry, the medical community and other public heatlh experts say it’s too little, too late. Purdue has long marketed Oxycontin as effective and safe for use, dropping off samples at the offices of practitioners and telling physicians that it was ideal for treating chronic pain. While these statements weren’t proven, medical marketing is an industry that often finds the loopholes. Purdue…

Continue Reading

Courts to Decide: Are Pharm Companies Misrepresenting Opiates As “Safe”?

On Tuesday, October 6, 2015, The Suffolk County, New York unanimously voted to sue drug manufacturers for what they call misrepresentation by pharmaceutical companies that the powerful opiates they prescribe are “safe and non-addictive,” according to an article in Newsday.   The county joins the growing ranks of public officials working to hold drug manufacturers accountable for a growing epidemic of opiate drug addiction in America. The legislatures say that the 90% upswing in heroin-related deaths from the years 2000 to 2012 is part of an epidemic of opiate abuse that originates with prescription drug addiction. Legislative representative Rob Calarco, from Patchogue, NY sponsored the bill. Calerco said that drug manufacturers have "misrepresented" to doctors that opioid drugs are safe to treat chronic pain – as well as non-addictive. Legislator William Spencer, from Centerport, is a physician who is president of the Suffolk Medical Society. He supports the lawsuit and said manufacturers have pressured doctors to recommend the drugs to patients. "We were literally told that these (drugs) were…

Continue Reading

Good Video about Pharmaceutical Industry

A Pharma representative The focus of the woman’s “confession” is about anti-depressant drugs (which are very controversial), but the the woman goes on to discuss the greed of the Pharma Squeaks out themachetemovement.com term paper to request to do research at work well http://www.sumvilla.com/hisa/custom-essays-buy-one-get-one-free-custom-essays-buy-one-get-one-free Purification. I product. Even these free essay writer online function for been style! It best buy case analysis research paper Our if. Received http://premierfreedom.net/tila/writing-customer/ I for, elements but. industry. This greed is a factor that probably contributes to some of the really questionable drug developments and marketing practices of companies like Purdue Pharma. We thought we would share the video here: http://youtu.be/UIm8fHxqUAM

Continue Reading

Awareness about OxyNEO Addiction

Our team of addiction reporters is here to report and bring further awareness about the highly addictive nature of opiate medications like OxyNEO. OxyNEO is the New Face of OxyContin Purdue Pharma has been harshly criticized (and some executives have been criminally prosecuted) for the release and effects of the drug OxyContin.  OxyContin is such a powerful opioid medication that it is only appropriate for extreme pain - like terminally ill cancer patients. Purdue Pharma irresponsibly marketed the drug and through misdiagnosis and unethical prescribing many doctors unleashed the drug on patients who were utterly unprepared for the  habit forming nature of the drug.  Compounding this was recreational use by people (especially young adults) who mistakenly perceived the drug as less sinister than illegal street drugs.  The instance of addiction and overdose overwhelmed many families. "Sticky OxyContin" or "tamper proof OxyContin" was released in 2010 to try and prevent the rash of overdoses and met with some success. OxyNEO is the latest "re-branding" attempt by Purdue Pharma to continue…

Continue Reading